Metraipolis › archive › dc_8553eec482cf

Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma After Prior Therapy: Final Results from the… — Europe PMC PMID:42449619

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42449619
DOI: 10.3390/cancers18132075
License (as archived): solo-consultazione
Archived: 2026-10-18T16:58:12.264Z
SHA-256 of the archived text: 2a6f447df9926f24140094ca2b7a89f512eebef3b8d8e67d7773baca4d507f79
Stable URL of this page: https://metraipolis.com/documento/dc_8553eec482cf

How to cite

Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma After Prior Therapy: Final Results from the… — Europe PMC PMID:42449619 — Europe PMC (en), https://europepmc.org/article/MED/42449619 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8553eec482cf (Metraipolis archive dc_8553eec482cf, sha256 2a6f447df9926f24140094ca2b7a89f512eebef3b8d8e67d7773baca4d507f79)

BibTeX

@misc{dc8553eec482cf,
  title = {Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma After Prior Therapy: Final Results from the… — Europe PMC PMID:42449619},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42449619},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8553eec482cf; sha256 2a6f447df9926f24140094ca2b7a89f512eebef3b8d8e67d7773baca4d507f79},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449619. Agents can read the archived copy with the MCP tool read_document.